{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:57:31Z","timestamp":1779242251524,"version":"3.51.4"},"reference-count":35,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"unspecified","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Hospital Organization","award":["Grant-in-Aid for Clinical Research"],"award-info":[{"award-number":["Grant-in-Aid for Clinical Research"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2024,9,10]]},"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The optimal number of lymph nodes to be dissected during lung cancer surgery to minimise the postoperative recurrence risk remains undetermined. This study aimed to elucidate the impact of the number of dissected lymph nodes on the risk of postoperative recurrence of non-small cell lung cancer (NSCLC) using machine learning algorithms and statistical analyses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively analysed 650 patients with NSCLC who underwent complete resection. Five machine learning models were trained using clinicopathological variables to predict postoperative recurrence. The relationship between the number of dissected lymph nodes and postoperative recurrence was investigated in the best-performing model using Shapley additive explanations values and partial dependence plots. Multivariable Cox proportional hazard analysis was performed to estimate the HR for postoperative recurrence based on the number of dissected nodes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The random forest model demonstrated superior predictive performance (area under the receiver operating characteristic curve: 0.92, accuracy: 0.83, F1 score: 0.64). The partial dependence plot of this model revealed a non-linear dependence of the number of dissected lymph nodes on recurrence prediction within the range of 0\u201320 nodes, with the weakest dependence at 10 nodes. A linear increase in the dependence was observed for \u226520 dissected nodes. A multivariable analysis revealed a significantly elevated risk of recurrence in the group with \u226520 dissected nodes in comparison to those with &lt;20 nodes (adjusted HR, 1.45; 95% CI 1.003 to 2.087).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The number of dissected lymph nodes was significantly associated with the risk of postoperative recurrence of NSCLC. The risk of recurrence is minimised when approximately 10 nodes are dissected but may increase when &gt;20 nodes are removed. Limiting lymph node dissection to approximately 20 nodes may help to preserve a favourable antitumour immune environment. These findings provide novel insights into the optimisation of lymph node dissection during lung cancer surgery.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2023-001926","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T19:15:14Z","timestamp":1727378114000},"page":"e001926","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of the number of dissected lymph nodes on machine learning-based prediction of postoperative lung cancer recurrence: a single-hospital retrospective cohort study"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8136-4970","authenticated-orcid":false,"given":"Kensuke","family":"Kojima","sequence":"first","affiliation":[{"name":"Department of General Thoracic Surgery, NHO Kinki Chuo Chest Medical Center, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Samejima","sequence":"additional","affiliation":[{"name":"Department of General Thoracic Surgery, NHO Kinki Chuo Chest Medical Center, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoichi","family":"Okishio","sequence":"additional","affiliation":[{"name":"Clinical Research Center, NHO Kinki Chuo Chest Medical Center, Osaka, Japan"},{"name":"Department of Thoracic Oncology, NHO Kinki Chuo Chest Medical Center, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiteru","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"Department of General Thoracic Surgery, NHO Kinki Chuo Chest Medical Center, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyungeun","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of General Thoracic Surgery, NHO Kinki Chuo Chest Medical Center, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Atagi","sequence":"additional","affiliation":[{"name":"Japan Community Health Care Organization, Yamato Koriyama Hospital, Nara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"2025083112241278000_11.1.e001926.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2012.09.030"},{"key":"2025083112241278000_11.1.e001926.2","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31824a9022"},{"key":"2025083112241278000_11.1.e001926.3","unstructured":"National Comprehensive Cancer Network . NCCN clinical practice guidelines in oncology (NCCN guidelines): non-small cell lung cancer, version 1. 2020. Available: https:\/\/www.nccn.org\/patients\/ guidelines\/cancers. Aspx#nsclc"},{"key":"2025083112241278000_11.1.e001926.4","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.21037\/jtd.2018.05.100","article-title":"Selective versus systematic lymph node dissection (other than sampling) for clinical N2-negative non-small cell lung cancer: a meta-analysis of observational studies","volume":"10","author":"Han","year":"2018","journal-title":"J Thorac Dis"},{"key":"2025083112241278000_11.1.e001926.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2009.07.024"},{"key":"2025083112241278000_11.1.e001926.6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jjco\/hyx170","article-title":"A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413)","volume":"48","author":"Hishida","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"2025083112241278000_11.1.e001926.7","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2016.09.09","article-title":"Lymph node dissection after pulmonary resection for lung cancer: a mini review","volume":"4","author":"Korasidis","year":"2016","journal-title":"Ann Transl Med"},{"key":"2025083112241278000_11.1.e001926.8","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31817dfced"},{"key":"2025083112241278000_11.1.e001926.9","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1016\/j.cllc.2020.09.015","article-title":"Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis","volume":"22","author":"He","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"2025083112241278000_11.1.e001926.10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41591-022-02189-0","article-title":"Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial","volume":"29","author":"Cascone","year":"2023","journal-title":"Nat Med"},{"key":"2025083112241278000_11.1.e001926.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00518-6"},{"key":"2025083112241278000_11.1.e001926.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.09.001"},{"key":"2025083112241278000_11.1.e001926.13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay3575","article-title":"Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy","volume":"12","author":"Francis","year":"2020","journal-title":"Sci Transl Med"},{"key":"2025083112241278000_11.1.e001926.14","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124507","article-title":"Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy","volume":"3","author":"Fransen","year":"2018","journal-title":"JCI Insight"},{"key":"2025083112241278000_11.1.e001926.15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17091-5","article-title":"Prediction algorithm for ICU mortality and length of stay using machine learning","volume":"12","author":"Iwase","year":"2022","journal-title":"Sci Rep"},{"key":"2025083112241278000_11.1.e001926.16","doi-asserted-by":"crossref","first-page":"16913","DOI":"10.1038\/s41598-022-20724-4","article-title":"Machine learning-based derivation and external validation of a tool to predict death and development of organ failure in hospitalized patients with COVID-19","volume":"12","author":"Xu","year":"2022","journal-title":"Sci Rep"},{"key":"2025083112241278000_11.1.e001926.17","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-020-0249-z","article-title":"Personalized predictions of patient outcomes during and after hospitalization using artificial intelligence","volume":"3","author":"Hilton","year":"2020","journal-title":"NPJ Digit Med"},{"key":"2025083112241278000_11.1.e001926.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103911","article-title":"A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models","volume":"77","author":"Hindocha","year":"2022","journal-title":"EBioMedicine"},{"key":"2025083112241278000_11.1.e001926.19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174150","article-title":"Lung Cancer Recurrence Risk Prediction through Integrated Deep Learning Evaluation","volume":"14","author":"Huang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025083112241278000_11.1.e001926.20","first-page":"12","article-title":"Impact of the number of resected lymph nodes during multi-portal VATS lobectomy for clinical N0 non-small cell lung cancer","volume":"5","author":"Park","year":"2020","journal-title":"Vidassist Thorac Surg"},{"key":"2025083112241278000_11.1.e001926.21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu242"},{"key":"2025083112241278000_11.1.e001926.22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.lungcan.2014.06.004","article-title":"Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung","volume":"85","author":"Vieira","year":"2014","journal-title":"Lung Cancer (Auckl)"},{"key":"2025083112241278000_11.1.e001926.23","doi-asserted-by":"publisher","DOI":"10.1177\/0218492313478431"},{"key":"2025083112241278000_11.1.e001926.24","doi-asserted-by":"crossref","DOI":"10.1186\/s13019-018-0763-0","article-title":"Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer","volume":"13","author":"Mizuguchi","year":"2018","journal-title":"J Cardiothorac Surg"},{"key":"2025083112241278000_11.1.e001926.25","unstructured":"Lundberg SM , Lee S-I , et al . A unified approach to interpreting model predictions. In: Guyon I , Luxburg UV , Bengio S , eds. Advances in neural information processing systems, 30. 2017: 4765\u201374."},{"key":"2025083112241278000_11.1.e001926.26","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(95)00048-8"},{"key":"2025083112241278000_11.1.e001926.27","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"2025083112241278000_11.1.e001926.28","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.3.1545"},{"key":"2025083112241278000_11.1.e001926.29","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.21037\/jtd-19-3773","article-title":"Prognostic impact of lymphadenectomy on outcomes of sublobar resection for non-small cell lung cancer \u22641 or >1 to 2 cm","volume":"12","author":"Zheng","year":"2020","journal-title":"J Thorac Dis"},{"key":"2025083112241278000_11.1.e001926.30","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.2147\/CMAR.S186047","article-title":"The number of resected lymph nodes is associated with the long-term survival outcome in patients with T2 N0 non-small cell lung cancer","volume":"10","author":"Wen","year":"2018","journal-title":"Cancer Manag Res"},{"key":"2025083112241278000_11.1.e001926.31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/10543406.2022.2148162","article-title":"Forecasting determinants of recurrence in lung cancer patients exploiting various machine learning models","volume":"33","author":"Thirunavukkarasu","year":"2023","journal-title":"J Biopharm Stat"},{"key":"2025083112241278000_11.1.e001926.32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.924144","article-title":"Explainable Machine Learning Model to Prediction EGFR Mutation in Lung Cancer","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"2025083112241278000_11.1.e001926.33","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax0182","article-title":"Neoadjuvant checkpoint blockade for cancer immunotherapy","volume":"367","author":"Topalian","year":"2020","journal-title":"Science"},{"key":"2025083112241278000_11.1.e001926.34","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.21037\/jtd-23-1806","article-title":"Impact of lymph node dissection on the efficacy of immune checkpoint inhibitors in patients with postoperative recurrence of non-small cell lung cancer","volume":"16","author":"Kawaguchi","year":"2024","journal-title":"J Thorac Dis"},{"key":"2025083112241278000_11.1.e001926.35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41591-020-0829-0","article-title":"Learning from clinical trials of neoadjuvant checkpoint blockade","volume":"26","author":"Versluis","year":"2020","journal-title":"N Med"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2023-001926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T19:24:29Z","timestamp":1756668269000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2023-001926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,9,26]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1136\/bmjresp-2023-001926"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2023-001926","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}